Serum levels of lipids and apolipoproteins in angiographically assessed coronary artery disease in Japanese patients. 1992

Y Sawada, and H Kotake, and A Hoshio, and K Ogino, and T Nawada, and I Hisatome, and Y Fujimoto, and H Mashiba
First Department of Internal Medicine, Tottori University School of Medicine, Yonago, Japan.

Serum total cholesterol (T-CHO), triglyceride (TG), high density lipoprotein cholesterol (HDL-C) and apolipoproteins (apo A-I, A-II, B, C-II, C-III and E) values were determined in 143 Japanese subjects undergoing coronary angiography. Among the factors measured, T-CHO, TG, apo B and C-III levels were significantly higher in patients with coronary artery disease (CAD) than in those without CAD. The HDL-C/T-CHO ratio was also significantly lower in patients with CAD. Although no parameters show differences between the group without CAD and the group of single vessel disease, T-CHO and apo B were significantly higher in the groups with double and triple vessel disease, and TG and apo C-III were also higher in the group with triple vessel disease compared with the normal group. Furthermore, the HDL-C/T-CHO ratio was significantly lower in the double and triple vessel groups, and HDL-C was lower only in the triple vessel group. The results indicate that changes in these parameters suggest a high likelihood of multiple vessel disease, and that an increase in TG and apo C-III levels is also one of the important indicators for CAD even in Japanese patients.

UI MeSH Term Description Entries
D008055 Lipids A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed) Lipid
D008076 Cholesterol, HDL Cholesterol which is contained in or bound to high-density lipoproteins (HDL), including CHOLESTEROL ESTERS and free cholesterol. High Density Lipoprotein Cholesterol,Cholesterol, HDL2,Cholesterol, HDL3,HDL Cholesterol,HDL(2) Cholesterol,HDL(3) Cholesterol,HDL2 Cholesterol,HDL3 Cholesterol,alpha-Lipoprotein Cholesterol,Cholesterol, alpha-Lipoprotein,alpha Lipoprotein Cholesterol
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001053 Apolipoproteins Protein components on the surface of LIPOPROTEINS. They form a layer surrounding the hydrophobic lipid core. There are several classes of apolipoproteins with each playing a different role in lipid transport and LIPID METABOLISM. These proteins are synthesized mainly in the LIVER and the INTESTINES. Apolipoprotein

Related Publications

Y Sawada, and H Kotake, and A Hoshio, and K Ogino, and T Nawada, and I Hisatome, and Y Fujimoto, and H Mashiba
January 1986, Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement,
Y Sawada, and H Kotake, and A Hoshio, and K Ogino, and T Nawada, and I Hisatome, and Y Fujimoto, and H Mashiba
January 1990, Journal of clinical epidemiology,
Y Sawada, and H Kotake, and A Hoshio, and K Ogino, and T Nawada, and I Hisatome, and Y Fujimoto, and H Mashiba
November 1989, Atherosclerosis,
Y Sawada, and H Kotake, and A Hoshio, and K Ogino, and T Nawada, and I Hisatome, and Y Fujimoto, and H Mashiba
January 1978, Chest,
Y Sawada, and H Kotake, and A Hoshio, and K Ogino, and T Nawada, and I Hisatome, and Y Fujimoto, and H Mashiba
January 2014, BioMed research international,
Y Sawada, and H Kotake, and A Hoshio, and K Ogino, and T Nawada, and I Hisatome, and Y Fujimoto, and H Mashiba
November 1984, American heart journal,
Y Sawada, and H Kotake, and A Hoshio, and K Ogino, and T Nawada, and I Hisatome, and Y Fujimoto, and H Mashiba
September 1991, Scandinavian journal of clinical and laboratory investigation,
Y Sawada, and H Kotake, and A Hoshio, and K Ogino, and T Nawada, and I Hisatome, and Y Fujimoto, and H Mashiba
November 1993, The Journal of the Association of Physicians of India,
Y Sawada, and H Kotake, and A Hoshio, and K Ogino, and T Nawada, and I Hisatome, and Y Fujimoto, and H Mashiba
January 1985, Annals of the New York Academy of Sciences,
Y Sawada, and H Kotake, and A Hoshio, and K Ogino, and T Nawada, and I Hisatome, and Y Fujimoto, and H Mashiba
January 1994, Atherosclerosis,
Copied contents to your clipboard!